M

MAIA Biotechnology
D

MAIA

1.09000
USD
0.13
(13.58%)
مغلق
حجم التداول
2,327
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
40,365,215
الأخبار المقالات

العنوان: MAIA Biotechnology

القطاع: Healthcare
الصناعة: Biotechnology
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.